Source-grounded facts extracted from Agriculture & Natural Solutions Acquisition Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Agriculture & Natural Solutions Acquisition Corp: Amended and restated the memorandum and articles of association to extend the business combination deadline from November 13, 2025 to up to November 13, 2026, and to make certain non-substantive changes (effective 2025-11-11).
“As approved by the Company’s shareholders at the extraordinary general meeting held on November 10, 2025 (the “Meeting”), the Company filed its Amended Articles with the Registrar of Companies in the Cayman Islands on November 11, 2025 in order to implement the Extension Amendment Proposal (as defined below).”
Debt Financings
Agriculture & Natural Solutions Acquisition Corp incurred loan of up to $7,901,336.88 with Agriculture & Natural Solutions Acquisition Warrant Holdings LLC at non-interest bearing maturing the earliest of: (a) the consummation of the Business Combination, (b) the expiration of the Completion Window or (c) the voluntary dissolution and liquidation.
“limited liability company (“Warrant Holdings Sponsor”) and an affiliate of Agriculture & Natural Solutions Acquisition Sponsor LLC, our sponsor, in the principal amount of up to $7,901,336.88 (the “Note”) in connection with the Extension (as defined below). Pursuant to the Note, Warrant Holdings Sponsor will deposit $658,444.74 into the Trust Fund (as defined in the”
Listing & Compliance Notices
Agriculture & Natural Solutions Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).
“February 11, 2025, Agriculture & Natural Solutions Acquisition Corporation (the "Company") received a notification letter from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market LLC ("Nasdaq") indi”
Listing & Compliance Notices
Agriculture & Natural Solutions Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2), 5605(c)(4)).
“April 30, 2024, the Company received a letter from Nasdaq confirming such non-compliance and confirming that, in accordance with Nasdaq Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance as follows: • Until the earlier of the Company’s next annual shareholders’ meeting or March 26, 2025; or • If the next annual shareholders’ meeting is held before September 23, 2024, then the Company must evidence compliance no later than September 23, 2024. The foregoing has no immediate effect on the Company’s Nasdaq listing and its securities will continue to be lis”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.